Hospital News and Research

RSS

MID completes enrollment in STASIS trial of Permaseal

Micro Interventional Devices, Inc. has completed enrollment in its Secure Transapical Access and Closure Study. STASIS is a non-randomized, multi-center, CE-Mark study, evaluating the safety and performance of Permaseal the world's first automated direct myocardial ventricular access and closure technology especially designed for use in transcatheter valve replacement procedures (TAVR and TMVR).

11 Jan 2015

Gaumard provides update on installations of Victoria birthing simulators in the U.S.

Gaumard Scientific Company today provided an update on installations of the Victoria birthing simulator at U.S. health care educational facilities.

11 Jan 2015

NCCN collaborates with Flatiron Health to create oncology outcomes database

The National Comprehensive Cancer Network is collaborating with Flatiron Health to create a cloud-based data repository of NCCN Member Institution data - the NCCN Outcomes Database.

9 Jan 2015

Orlando Regional Medical Center opens new patient tower

As the new year begins, Orlando Health turns the page to a new chapter in patient, guest and team member experience, when Orlando Regional Medical Center opens its new patient tower.

9 Jan 2015

Sustained quality improvement changes in ICU benefits both patients and health care facility

In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.

9 Jan 2015

CHLA scientists grow tissue-engineered small intestine from human cells

A new study by researchers at Children's Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.

9 Jan 2015

Latest wearable tracking devices alone may not change health behavior, say Penn researchers

New Year's weight loss resolutions are in full swing, but despite all the hype about the latest wearable tracking devices, there's little evidence that this technology alone can change behavior and improve health for those that need it most, according to a new online-first viewpoint piece in JAMA.

9 Jan 2015

Tips to avoid winter slips and falls

Tread lightly and don't get too confident; winter is officially here and sidewalks are slippery. About 1 million people take a tumble every year and, according to the Centers for Disease Control and Prevention, approximately 20,000 people die annually due to fall-related injuries.

9 Jan 2015

VolitionRx's NuQ blood-based diagnostic platform demonstrates promising results in clinical study

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that it has completed a blinded clinical study demonstrating that its NuQ® blood-based diagnostic platform is able to accurately detect 84% of early, surgically-treatable pancreatic cancers at high 92% specificity.

8 Jan 2015

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

JHQ special issue focuses on 'Transitions in Care'

The current issue of the Journal for Healthcare Quality is devoted entirely to an increasingly significant concern in healthcare quality management - how to assure favorable outcomes when transitioning patients from one clinical environment to another or to the home.

8 Jan 2015

Current flu vaccine still offers protection, says Loyola infectious disease specialist

In baseball, three strikes and you're out. The most common annual vaccine targets three strains of flu virus. This year, two vaccine strains are spot on and successfully matched. One strain is partially mismatched, but still believed to offer partial coverage for that strain. The current flu vaccine is still in the game and, more importantly, keeping people well and on the playing field, says a Loyola University Medical Center infectious disease specialist.

8 Jan 2015

Better physical functioning associated with remission of general anxiety, PTSD symptoms

In a two-year longitudinal study involving 13 intensive care units in four U.S. hospitals, researchers found that better physical functioning — basic and complex activities considered essential for maintaining independence — is associated with remission of general anxiety and post-traumatic stress disorder (PTSD) symptoms. These findings may help clinicians be better prepared for caring for the growing number of survivors of critical illness, potentially leading to a better quality of recovery for patients.

8 Jan 2015

Johns Hopkins-led study offers strategy to eradicate HIV

Luring dormant HIV out of hiding and destroying its last cure-defying holdouts has become the holy grail of HIV eradication, but several recent attempts to do so have failed. Now the findings of a Johns Hopkins-led study reveal why that is and offer a strategy that could form a blueprint for a therapeutic vaccine to eradicate lingering virus from the body.

8 Jan 2015

Improving headache treatment could reduce health care spending, new study suggests

Each year more than 12 million Americans visit their doctors complaining of headaches, which result in lost productivity and costs of upward of $31 billion annually. A new study by researchers from Beth Israel Deaconess Medical Center suggests some of that cost could be offset by physicians ordering fewer tests and an increased focus on counseling about lifestyle changes.

8 Jan 2015

Combination therapy can reduce recurrence of small, HER2-positive breast tumors

In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.

8 Jan 2015

Testosterone therapy suppresses some advanced prostate cancers, find Johns Hopkins scientists

In a surprising paradox, the male hormone testosterone, generally thought to be a feeder of prostate cancer, has been found to suppress some advanced prostate cancers and also may reverse resistance to testosterone-blocking drugs used to treat prostate cancer.

8 Jan 2015

Protecting children in advance from head injuries helps reduce brain trauma

An exhaustive analysis of data from more than 40,000 cases of brain trauma in children - published by the authoritative New England Journal of Medicine - provides convincing evidence that protecting children in advance from head injuries is the key to reducing their severity.

7 Jan 2015

Study: Synthetic triglyceride oil may provide hope for people with Huntington's disease

An early study suggests that a synthetic triglyceride oil called triheptanoin may provide hope for people with Huntington's disease. The study is published in the January 7, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Jan 2015

Capsule Tech announces availability of healthcare's first medical device information system

Capsule Tech, Inc., the leading global provider of medical device integration solutions, recently announced the general availability of SmartLinx, healthcare's first medical device information system (MDIS).

7 Jan 2015

Hospital News and Research

MID completes enrollment in STASIS trial of Permaseal

Gaumard provides update on installations of Victoria birthing simulators in the U.S.

NCCN collaborates with Flatiron Health to create oncology outcomes database

Orlando Regional Medical Center opens new patient tower

Sustained quality improvement changes in ICU benefits both patients and health care facility

CHLA scientists grow tissue-engineered small intestine from human cells

Latest wearable tracking devices alone may not change health behavior, say Penn researchers

Tips to avoid winter slips and falls

VolitionRx's NuQ blood-based diagnostic platform demonstrates promising results in clinical study

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

JHQ special issue focuses on 'Transitions in Care'

Current flu vaccine still offers protection, says Loyola infectious disease specialist

Better physical functioning associated with remission of general anxiety, PTSD symptoms

Johns Hopkins-led study offers strategy to eradicate HIV

Improving headache treatment could reduce health care spending, new study suggests

Combination therapy can reduce recurrence of small, HER2-positive breast tumors

Testosterone therapy suppresses some advanced prostate cancers, find Johns Hopkins scientists

Protecting children in advance from head injuries helps reduce brain trauma

Study: Synthetic triglyceride oil may provide hope for people with Huntington's disease

Capsule Tech announces availability of healthcare's first medical device information system

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News